A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
about
The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluationPirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapyPharmacological management of IPFPatient considerations and drug selection in the treatment of idiopathic pulmonary fibrosisNew perspectives on management of idiopathic pulmonary fibrosisPharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future PerspectivesUnder-recognised co-morbidities in idiopathic pulmonary fibrosis: A reviewManaging comorbidities in idiopathic pulmonary fibrosisPulmonary hypertension: diagnostic and therapeutic challengesAcute and subacute idiopathic interstitial pneumoniasThe psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature reviewRight ventricular dysfunction in chronic lung diseaseExtending the translational potential of targeting NO/cGMP-regulated pathways in the CVSIdiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challengesUpdate on diagnosis and treatment of idiopathic pulmonary fibrosisUpdate on therapeutic management of idiopathic pulmonary fibrosisYear in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung diseaseAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementAdverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trialsAssociation of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trialsStudy design implications of death and hospitalization as end points in idiopathic pulmonary fibrosisPredicting pulmonary fibrosis disease course from past trends in pulmonary function.Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.Fibrocytes and the pathogenesis of diffuse parenchymal lung disease.Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registryNew therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumoniaProtocol for a mixed-methods study of supplemental oxygen in pulmonary fibrosis.Pirfenidone treatment of idiopathic pulmonary fibrosis.Novel therapeutic approaches for pulmonary fibrosis.An official American Thoracic Society Statement: pulmonary hypertension phenotypesReview: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesPharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung diseaseLung transplantation for pulmonary hypertension.Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centersPulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.Interstitial lung abnormalities and reduced exercise capacity.
P2860
Q21195756-FA57D998-535B-4C62-A5DD-D71503A15FACQ26738458-780014E4-2E95-4DCA-A3EF-3EEB2998326CQ26748808-4DEE6AD7-6AD2-4175-AE7C-5CA70465C11CQ26750418-B7EDF1F8-4C8E-42FC-AC65-309CD1B34BDAQ26765586-4891446B-6C7B-4A8B-8A59-AFDA93098FBDQ26771309-24E910D0-6EC9-4B12-811F-83F07CD273CEQ26781255-6A3B15CA-590F-4F0D-88BB-2DDD674047ACQ26785617-8646166B-2F7C-461E-A415-8D771F6FD157Q26796434-F2EC95A4-503B-48E4-83CD-3864AEDA6FE0Q26824327-B6FB7672-2E50-4FEE-8B3B-55E27C0D0EFFQ26992007-2D79A3F8-734F-4B38-B8DF-FD2177F26749Q27002670-9B32D369-ED14-49BD-A39D-5832304D5067Q27021649-7A046EDD-196C-40B3-AA5F-A9E2A7F556B3Q27499290-10DCFCD3-D297-4F22-A6C9-9B2F58E9E6E3Q28083702-0E251A8A-555D-4E0F-89E3-2D61949BB9A8Q28083944-A260D30A-6AFC-406C-92D2-D2E0CFF4FA23Q28085094-F2DA17A5-1DEE-4008-9328-9BF30962A450Q28308246-DA28E4E0-7961-45E5-8C1C-C061CF61F508Q28484304-C0D2C72A-46EE-429E-836A-63F8AC2141E6Q30359367-5ACACA50-A96B-4591-B5C0-83A1CA6785B2Q30370058-B454D538-F95C-4A42-A667-E8A71BE6BB5DQ30407660-037A5F9F-85E8-4C08-8747-EEF76260BD10Q30412203-9DFFC4B7-5240-438B-BDE8-3FAFDB9986ACQ30412726-59485806-55B5-4736-B17A-5C70ED93F496Q30426516-45255534-F5D3-4681-8F28-5A7EC33D432FQ33738724-1EB3788B-AD97-4A44-982B-BB0734AE71F6Q33908569-E7A78CAB-69AF-4BBA-ACB6-D19548C122D9Q34432217-F5A2CAEB-10DF-4B95-8271-6BC6020C3B22Q34480466-8F9FB433-067F-482D-9B3C-366E2238DCC3Q34515601-589E2258-46B6-4AE4-9947-F80FE734819EQ34574174-18C0B751-363F-40E9-8484-38162C79C103Q34903224-1BE73D09-4620-44D1-9BC6-7C7AC6CA0EF5Q34919733-A3E3FC26-352F-4253-814C-3CB3123BB48BQ35121494-4FE85968-8BC9-4A18-B449-6EA99C3D3C0AQ35156618-627D0D61-9550-41BE-A390-BE70B19E78DDQ35164509-5EF0BAA1-78FB-425D-9AEA-D85FE44C31E6Q35412426-077F851E-E4E2-42F7-B845-27502E3E8F53Q35665777-4F26C00C-9F5A-4542-87AD-6B32B4A0C7BBQ35858996-60240258-A54D-4F4F-8382-61F892239B17Q35889148-6C481BA6-D136-4F20-A0CC-5613AED8F4EF
P2860
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@ast
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@en
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@nl
type
label
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@ast
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@en
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@nl
prefLabel
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@ast
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@en
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@nl
P2093
P2860
P356
P1476
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis.
@en
P2093
David A Zisman
Gary W Hunninghake
Harold R Collard
Idiopathic Pulmonary Fibrosis Clinical Research Network
Kevin R Flaherty
Marvin Schwarz
P2860
P304
P356
10.1056/NEJMOA1002110
P407
P577
2010-05-18T00:00:00Z